PCV38 LIPID LOWERING MEDICATIONS FOLLOWING CORONARY REVASCULARIZATION PROCEDURES

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The use of cholesterol-lowering medications after coronary revascularization.

BACKGROUND In clinical trials, cholesterol-lowering medications have been proven to decrease mortality and morbidity and are strongly recommended as secondary prevention for patients with established coronary artery disease. Whether physicians and patients follow this recommendation is unknown. Our objective was to determine the rate at which patients fill at least one prescription for choleste...

متن کامل

Carvedilol: A Promising Drug Combined with Lipid-lowering Medications for Patients with Hypertension and Heart Failure

Background: Statins frequently cause myopathy especially in combination with fibrates, and physical activity is considered a trigger for the muscle disorder. Elevated plasma levels of creatine kinase (CK), lactate dehydrogenase (LDH) and aldolase, are the main indicators of the severity of myopathy. Carvedilol is commonly used with lipid-lowering drugs in the management of heart failure, hypert...

متن کامل

Cardiovascular risk changes after lipid lowering medications: are they predictable?

Changes in cardiovascular risk after lipid lowering medications are generally expressed as relative risk reduction (RRR). Comparison of the eight major studies published in this last decade indicates that the RRRs ranged from a minimum (19%) for the LRC Study with cholestyramine, to maximal values of 34-37% for studies such as the HHS, 4S and AFCAPS/TexCAPS. These RRRs were barely related to th...

متن کامل

Use of coronary angiography and revascularization procedures following acute myocardial. A European perspective

*Division of Clinical Pharmacology, Leicester Royal Infirmary, Leicester, U.K.; †Department of Clinical Pharmacology, CSU Vall Hebron, Barcelona, Spain; ‡Clinic for Internal Medicine, University of Innsbruck, Innsbruck, Austria; §Maria Hospital, Helsinki, Finland; QHygeia Hospital, Athens, Greece; ¶Unite de Pharmacologie Clinique, Lyon, France; **Research Forum, Ulleval University Hospital, Osl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2002

ISSN: 1098-3015

DOI: 10.1016/s1098-3015(10)61309-5